(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.87% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Avanos Medical's revenue in 2025 is $687,800,000.On average, 2 Wall Street analysts forecast AVNS's revenue for 2025 to be $31,281,911,984, with the lowest AVNS revenue forecast at $31,052,126,250, and the highest AVNS revenue forecast at $31,511,697,719. On average, 2 Wall Street analysts forecast AVNS's revenue for 2026 to be $32,173,683,047, with the lowest AVNS revenue forecast at $32,077,996,495, and the highest AVNS revenue forecast at $32,269,369,599.
In 2027, AVNS is forecast to generate $33,120,427,874 in revenue, with the lowest revenue forecast at $33,118,587,748 and the highest revenue forecast at $33,122,268,000.